Skip to main content

Table 1 A-to-I editing in different tumours

From: Biological roles of A-to-I editing: implications in innate immunity, cell death, and cancer immunotherapy

Cancer

Gene

Protein

Substrate type

Editing residue (s)

References

Hepatocellular carcinoma

AZIN1

Antizyme inhibitor 1

Coding gene

S/G

[62]

BLCAP

Bladder cancer-associated protein

Coding gene

Y/C

[68]

ITGA2

Integrin alpha 2

Coding gene

 

[70]

circARSP91

 

circRNA

circRNA

[71, 72]

Esophageal squamous cell carcinoma

AZIN1

Antizyme inhibitor 1

Coding gene

S/G

[73]

Colorectal carcinoma

AZIN1

Antizyme inhibitor 1

Coding gene

S/G

[74, 75]

Gastric cancer

hsa_circ_0004872

 

circRNA

circRNA

[76]

Pancreatic ductal adenocarcinoma

circNEIL3

 

circRNA

circRNA

[77]

Non-small-cell lung cancer

AZIN1

Antizyme inhibitor 1

Coding gene

S/G

[65]

Lung adenocarcinoma

FAK

Focal adhesion kinase

Intron

 

[34]

Multiple myeloma

GLI1

Glioma-associated oncogene 1

Coding gene

R/G

[78]

NEIL1

Endonuclease 8-like 1

Coding gene

K/R

[79]

Melanoma

CCNI

Cyclin I

Coding gene

R/G

[24]

miR-455-5p

 

miRNA

miRNA

[69]

miR-378a-3p

 

miRNA

miRNA

[80]

miR-222

 

miRNA

miRNA

[81]

miRNA-149-3p

 

miRNA

miRNA

[82]

Breast invasive carcinoma

GABRA3

Gamma-aminobutyric acid receptor subunit alpha-3

Coding gene

I/M

[67]

ARHGAP26

RhoA GTPase activating protein 26

3′ UTR

3′ UTR

[83]

DHFR

Dihydrofolate reductase

3′ UTR

3′ UTR

[84]

DFFA

DNA fragmentation factor alpha

3′ UTR

3′ UTR

[27]

LINC00944

 

LncRNA

lncRNA

[85]

Cervical squamous cell carcinoma and endocervical adenocarcinoma

BLCAP

Bladder cancer-associated protein

Coding gene

Y/C; Q/R; K/R

[86]

Thyroid cancer

CDK13

 

Coding gene

Q/R

[87, 88]

miR-200b

 

miRNA

miRNA

[89]

Prostate adenocarcinoma

PCA3

Prostate cancer antigen 3

LncRNA

Duplex with PRUNE2

[90]

Chronic myelogenous leukemia

pri-let-7d

   

[91]